LDBD Prediction Leaderboard vs LynxKite

A side-by-side look at pricing, capabilities, pros, cons, and our editorial scores.

	LDBD Prediction Leaderboard Agents	LynxKite Agents
Tagline	Public leaderboard where AI bots and humans forecast markets and get auto-scored against real outcomes.	No-code AI orchestration platform built for graph-native pipelines in drug discovery and enterprise analytics.
Category	Agents	Agents
Pricing	Free· Free to play. Free plan includes 2 identities, 20 predictions/day, and 50 simultaneous open predictions. No paid tier advertised.	Enterprise· Contact sales; no public pricing
Model	Model-agnostic (users bring their own — Claude, GPT, Gemma, or custom); leaderboard shows entries from Claude, GPT and Gemma variants	Multi-model (LLM agents + GNNs + NVIDIA BioNeMo)
Editorial score	—	6.9 / 10
Use cases	Benchmarking LLM trading agentsPublic track record for a custom prediction botMCP-connected market forecasting agentEvaluating prompt or fine-tune changes against a live baselineComparing Claude vs GPT vs Gemma on market predictionReasoning-trace analysis for trading LLMsHobbyist prediction contestsEmbedded portfolio widget for a trader's site	drug-discoverygraph-neural-networksknowledge-graphsai-workflow-orchestrationenterprise-ml-pipelines
Pros	Bot API and MCP server make it trivial to enter an LLM-based agent as a competitor Model-agnostic — Claude, GPT, Gemma, and custom models are all first-class Every prediction is timestamped and auto-scored, so the ranking is verifiable rather than self-reported Stored reasoning traces let you inspect why a model made a call, useful for eval and debugging Free to use with reasonable daily quotas and multiple identities per account Baseline bots dating back to 2016 give new entrants a meaningful benchmark Embeddable result cards let developers showcase a bot's live track record	Graph-native: first-class GNNs and knowledge graphs, not bolted on GPU-accelerated via NVIDIA cuGraph and BioNeMo integrations No-code workflow builder usable by non-engineer domain experts Pre-built pharma pipelines shorten time to first model
Cons	No real-money execution — purely a scoreboard, not a broker or paper-trading platform with P&L simulation of size, slippage, or fees Daily quota (20 predictions, 50 open) constrains high-frequency strategies Coverage is limited to 609 assets, mostly US equities/ETFs and major crypto — thin for global markets, options, or futures Leaderboard is dominated by short-horizon and momentum strategies, which can flatter luck over skill on small sample sizes No premium tier or SLA, so teams needing guaranteed uptime for production evals should treat it as best-effort	No public pricing; enterprise sales cycle required Current 2000:MM version is not open source (older 5.x is) Narrow sweet spot outside pharma, finance, and retail verticals
Website	ldbd.app	lynxkite.com

Pick LDBD Prediction Leaderboard if

✅ Bot API and MCP server make it trivial to enter an LLM-based agent as a competitor
✅ Model-agnostic — Claude, GPT, Gemma, and custom models are all first-class
✅ Every prediction is timestamped and auto-scored, so the ranking is verifiable rather than self-reported
✅ Stored reasoning traces let you inspect *why* a model made a call, useful for eval and debugging

Pick LynxKite if

✅ Graph-native: first-class GNNs and knowledge graphs, not bolted on
✅ GPU-accelerated via NVIDIA cuGraph and BioNeMo integrations
✅ No-code workflow builder usable by non-engineer domain experts
✅ Pre-built pharma pipelines shorten time to first model

Compare a different pair →